000			01655 a2200457 4500
005			20250515100659.0
264		0	_c20080220
008			200802s 0 0 eng d
022			_a0041-1345
024	7		_a10.1016/j.transproceed.2007.07.085 _2doi
040			_aNLM _beng _cNLM
100	1		_aZimmerman, M A
245	0	0	_aAntiviral prophylaxis and recurrence of hepatocellular carcinoma following liver transplantation in patients with hepatitis B. _h[electronic resource]
260			_bTransplantation proceedings _cDec 2007
300			_a3276-80 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnalysis of Variance
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aCarcinoma, Hepatocellular _xcomplications
650	0	4	_aDisease-Free Survival
650	0	4	_aHepatitis B _xcomplications
650	0	4	_aHumans
650	0	4	_aImmunoglobulins _xtherapeutic use
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aLiver Neoplasms _xcomplications
650	0	4	_aNeoplasm Staging
650	0	4	_aPostoperative Complications _xprevention & control
650	0	4	_aRecurrence
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Analysis
650	0	4	_aSurvivors
650	0	4	_aTime Factors
650	0	4	_aVirus Diseases _xepidemiology
700	1		_aGhobrial, R M
700	1		_aTong, M J
700	1		_aHiatt, J R
700	1		_aCameron, A M
700	1		_aBusuttil, R W
773	0		_tTransplantation proceedings _gvol. 39 _gno. 10 _gp. 3276-80
856	4	0	_uhttps://doi.org/10.1016/j.transproceed.2007.07.085 _zAvailable from publisher's website
999			_c17602110 _d17602110